المؤلفون: Rodrigues-Ferreira, Sylvie, Nehlig, Anne, Monchecourt, Clarisse, Nasr, Sarah, Fuhrmann, Laetitia, Lacroix-Triki, Magali, Garberis, Ingrid, Scott, Véronique, Delaloge, Suzette, Pistilli, Barbara, Vielh, Philippe, Dubois, Thierry, Vincent-Salomon, Anne, André, Fabrice, Nahmias, Clara

المساهمون: Biomarqueurs prédictifs et nouvelles stratégies moléculaires en thérapeutique anticancéreuse (U981), Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM), Laboratoire d'Excellence en Recherche sur le Médicament et l'Innovation Thérapeutique Châtenay-Malabry (LabEx LERMIT), Université Paris-Sud - Paris 11 (UP11)-Institut National de la Santé et de la Recherche Médicale (INSERM), Inovarion, Département de médecine oncologique Gustave Roussy, Institut Gustave Roussy (IGR), Institut Curie Paris, Département de biologie et pathologie médicales Gustave Roussy, ANR-11-IDEX-0001,Amidex,INITIATIVE D'EXCELLENCE AIX MARSEILLE UNIVERSITE(2011)

المصدر: ISSN: 0167-6806.

مصطلحات موضوعية: Biomarkers combination, Breast cancer, Diagnosis, MAPRE1, MTUS1, Prognosis, [SDV.CAN]Life Sciences [q-bio]/Cancer, [SDV.BBM.GTP]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Genomics [q-bio.GN]

Relation: info:eu-repo/semantics/altIdentifier/pmid/30368744; hal-02411558; https://hal.science/hal-02411558; https://hal.science/hal-02411558/document; https://hal.science/hal-02411558/file/SRF%20EB1-ATIP3%20revised%20BREA2019%20for%20HAL-Inserm.pdf; PUBMED: 30368744

الاتاحة: https://hal.science/hal-02411558
https://hal.science/hal-02411558/document
https://hal.science/hal-02411558/file/SRF%20EB1-ATIP3%20revised%20BREA2019%20for%20HAL-Inserm.pdf
https://doi.org/10.1007/s10549-018-5026-1

المؤلفون: Thierry Dubois, Anne Vincent-Salomon, Anne Nehlig, Véronique Scott, Sarah Nasr, Fabrice Andre, Sylvie Rodrigues-Ferreira, Magali Lacroix-Triki, Barbara Pistilli, Ingrid Garberis, Clarisse Monchecourt, Suzette Delaloge, Laetitia Fuhrmann, Philippe Vielh, Clara Nahmias

المساهمون: NAHMIAS, Clara, Biomarqueurs prédictifs et nouvelles stratégies moléculaires en thérapeutique anticancéreuse (U981), Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM), Laboratoire d'Excellence en Recherche sur le Médicament et l'Innovation Thérapeutique [Châtenay-Malabry] (LabEx LERMIT), Université Paris-Sud - Paris 11 (UP11)-Institut National de la Santé et de la Recherche Médicale (INSERM), Inovarion, Département de médecine oncologique [Gustave Roussy], Institut Gustave Roussy (IGR), Institut Curie [Paris], Département de biologie et pathologie médicales [Gustave Roussy]

المصدر: Breast Cancer Research and Treatment
Breast Cancer Research and Treatment, 2019, 173 (3), pp.573-583. ⟨10.1007/s10549-018-5026-1⟩
Breast Cancer Research and Treatment, Springer Verlag, 2019, 173 (3), pp.573-583. ⟨10.1007/s10549-018-5026-1⟩

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, Population, Prognosis, Gene Expression, Breast Neoplasms, [SDV.CAN]Life Sciences [q-bio]/Cancer, Malignancy, Transcriptome, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, [SDV.CAN] Life Sciences [q-bio]/Cancer, Recurrence, Biomarkers combination, Internal medicine, [SDV.BBM.GTP]Life Sciences [q-bio]/Biochemistry, Molecular Biology/Genomics [q-bio.GN], Diagnosis, Biomarkers, Tumor, Medicine, Humans, education, MAPRE1, education.field_of_study, Tissue microarray, business.industry, Tumor Suppressor Proteins, medicine.disease, Survival Analysis, 3. Good health, MTUS1, 030104 developmental biology, 030220 oncology & carcinogenesis, Cohort, Biomarker (medicine), Immunohistochemistry, [SDV.BBM.GTP] Life Sciences [q-bio]/Biochemistry, Molecular Biology/Genomics [q-bio.GN], Female, Neoplasm Grading, business, Microtubule-Associated Proteins

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b050c473218a6cb122134337d01587e9
https://hal.science/hal-02411558

المؤلفون: Ascierto, Paolo A, Puzanov, Igor, Agarwala, Sanjiv S, Bifulco, Carlo, Botti, Gerardo, Caracò, Corrado, Ciliberto, Gennaro, Davies, Michael A, Dummer, Reinhard, Ferrone, Soldano, Gajewski, Thomas F, Garbe, Claus, Luke, Jason J, Marincola, Francesco M, Masucci, Giuseppe, Mehnert, Janice M, Mozzillo, Nicola, Palmieri, Giuseppe, Postow, Michael A, Schoenberger, Stephen P, Wang, Ena, Thurin, Magdalena

المصدر: Ascierto, Paolo A; Puzanov, Igor; Agarwala, Sanjiv S; Bifulco, Carlo; Botti, Gerardo; Caracò, Corrado; Ciliberto, Gennaro; Davies, Michael A; Dummer, Reinhard; Ferrone, Soldano; Gajewski, Thomas F; Garbe, Claus; Luke, Jason J; Marincola, Francesco M; Masucci, Giuseppe; Mehnert, Janice M; Mozzillo, Nicola; Palmieri, Giuseppe; Postow, Michael A; Schoenberger, Stephen P; Wang, Ena; Thurin, Magdalena (2018). Perspectives in melanoma: Meeting report from the Melanoma Bridge (30 November-2 December, 2017, Naples, Italy). Journal of Translational Medicine, 16(1):207.

مصطلحات الفهرس: Dermatology Clinic, 610 Medicine & health, General Biochemistry, Genetics and Molecular Biology, General Medicine, Biomarkers; Combination strategies; Immunotherapy; Melanoma; Target therapy, Journal Article, PeerReviewed, info:eu-repo/semantics/article, info:eu-repo/semantics/publishedVersion

URL: https://www.zora.uzh.ch/id/eprint/152907/
https://www.zora.uzh.ch/id/eprint/152907
10.1186/s12967-018-1568-6